Skip to main content
FinSpry Logo
FinSpry
OVID logo
OVID
(NASDAQ)
Ovid Therapeutics Inc.
$2.20-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Ovid Therapeutics (OVID) Stock Price & Financial Analysis

Ovid Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$2.08 - $2.22
52-Week High$2.72
52-Week Low$0.24
Open$2.13
Volume1.40M
Average Volume (3M)1.40M
Market Cap156.45M
Shares Outstanding71.12M
Price to Sales (P/S)23.24
Price to Book (P/B)3.44
EV/EBITDA-3.63
Revenue (TTM)6.61M
Net Income (TTM)-36.33M
Free Cash Flow (TTM)-37.96M
EPS (TTM)$-0.51
Profit Margin-549.62%
Operating Margin-618.26%
Return on Equity (ROE)-81.28%
Debt to Equity0.31
50-Day MA$1.83
200-Day MA$1.34
52-Week Change597.45%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Ovid Therapeutics

What is the current stock price for OVID?

As of the latest trading session, OVID stock trades at $2.20. The 52-week range is $0.24–$2.72, with a day range of $2.08–$2.21.

What is the P/E ratio for OVID?

The P/E ratio (Price-to-Earnings) for OVID is shown in the Key Statistics section. This valuation metric helps compare Ovid Therapeutics Inc. to industry peers.

Does OVID pay dividends?

Ovid Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for OVID?

Based on 2 analysts, the consensus for OVID is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of OVID?

Ovid Therapeutics's market capitalization is $156.5M, classifying it as a micro-cap company. Ovid Therapeutics operates in the Healthcare sector within the Biotechnology industry.